{'fraction_non_alphanumeric': 0.02236842105263158, 'fraction_numerical': 0.011842105263157895, 'mean_word_length': 4.7218045112781954, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
News at a glance.

BRAZZAVILLE | At least 360,000 babies and toddlers will receive the world’s first approved malaria vaccine starting next year, the World Health Organization’s Regional Office for Africa said this week. The RTS,S vaccine, which has shown only mediocre results in clinical trials, will be used in pilot programs in Ghana, Kenya, and Malawi. The vaccine does not fully protect against the disease. However, the trials did show that it offered some protection to children in regions with high malaria transmission who received four shots between the ages of 5 and 17 months. The program will test how feasible delivering the four required doses is and whether the vaccine offers the same protection on a large scale as it did in clinical trials.